Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Xyloglucan nasal spray in allergic rhinitis children
TCTR20240318004Phase 3Unknown
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Jun 2023
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of galacto-xyloglucan in allergic rhinitis (AR), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Status: unknown.
02
Drugs
galacto-xyloglucan
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20240318004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240318004.